148 related articles for article (PubMed ID: 3030641)
1. Protective immunity against herpetic ocular disease in an outbred mouse model.
Metcalf JF; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease.
Metcalf JF; Koga J; Chatterjee S; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):173-7. PubMed ID: 3030642
[TBL] [Abstract][Full Text] [Related]
3. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
Metcalf JF; Chatterjee S; Koga J; Whitley RJ
Intervirology; 1988; 29(1):39-49. PubMed ID: 2838428
[TBL] [Abstract][Full Text] [Related]
4. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
[TBL] [Abstract][Full Text] [Related]
5. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.
Tullo AB; Shimeld C; Blyth WA; Hill TJ; Easty DL
J Gen Virol; 1982 Nov; 63 (Pt 1)():95-101. PubMed ID: 6294236
[TBL] [Abstract][Full Text] [Related]
6. Study of HSV-1 DNA species from trigeminal ganglia of rabbits during acute and latent infections.
Green MT; Qavi HB; SeGall GK
Curr Eye Res; 1987 Jan; 6(1):85-9. PubMed ID: 3030658
[TBL] [Abstract][Full Text] [Related]
7. Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse.
Shimeld C; Tullo AB; Hill TJ; Blyth WA; Easty DL
Arch Virol; 1985; 85(3-4):175-87. PubMed ID: 2992417
[TBL] [Abstract][Full Text] [Related]
8. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
Harney BA; Easty DL; Skinner GR
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
Thompson P; Wells PA; Sandstrom IK; Opremcak EM; Millin JA; Daigle JA; Foster CS
Curr Eye Res; 1988 Nov; 7(11):1043-9. PubMed ID: 2854036
[TBL] [Abstract][Full Text] [Related]
10. Colonization of murine ganglia by a superinfecting strain of herpes simplex virus.
Meignier B; Norrild B; Roizman B
Infect Immun; 1983 Aug; 41(2):702-8. PubMed ID: 6307880
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant.
Gordon YJ; Rao H; Arullo-Cruz T
Curr Eye Res; 1984 Apr; 3(4):651-7. PubMed ID: 6325093
[TBL] [Abstract][Full Text] [Related]
13. Recovery of herpes simplex virus from the corneas of experimentally infected rabbits.
Cook SD; Batra SK; Brown SM
J Gen Virol; 1987 Jul; 68 ( Pt 7)():2013-7. PubMed ID: 3037020
[TBL] [Abstract][Full Text] [Related]
14. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice.
Abghari SZ; Stulting RD
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):239-43. PubMed ID: 2828265
[TBL] [Abstract][Full Text] [Related]
15. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
[TBL] [Abstract][Full Text] [Related]
16. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.
Nesburn AB; Ghiasi H; Wechsler SL
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1497-502. PubMed ID: 2167298
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits.
Green MT; Dunkel EC; Pavan-Langston D
Exp Eye Res; 1987 Sep; 45(3):375-83. PubMed ID: 2822456
[TBL] [Abstract][Full Text] [Related]
19. Herpetic ganglionic latency. Aciclovir and vidarabine therapy.
Pavan-Langston D; Park NH; Lass JH
Arch Ophthalmol; 1979 Aug; 97(8):1508-10. PubMed ID: 223531
[TBL] [Abstract][Full Text] [Related]
20. Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection.
Nesburn AB; Cook ML; Stevens JG
Arch Ophthalmol; 1972 Oct; 88(4):412-7. PubMed ID: 4342439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
